Inventor · disambiguated record
Rohan Mendonca
Also filed as: MENDONCA ROHAN · MENDONCA ROHAN V
15 granted patents·13 pending applications·118 citations·filing 2000–2023
91Inventor score
Top patents by PatentIndex Score
28 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0295US6506733B1Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2000·Granted Jan 14, 2003·40 cites·18 claims
- 0391US9346815B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2015·Granted May 24, 2016·5 cites·20 claims
- 0490US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0589US8461328B2Tricyclic heterocyclic compounds, compositions and methods of use thereofBABU SRINIVASAN·Filed 2011·Granted Jun 11, 2013·36 cites·18 claims
- 0688US9604984B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2016·Granted Mar 28, 2017·4 cites·21 claims
- 0787US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0885US2024150364A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 0981US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1080US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 1180US10800780B2TDO2 InhibitorsGENENTECH INC·Filed 2016·Granted Oct 13, 2020·4 cites·17 claims
- 1277US2022389020A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1376US11603373B2TDO2 and IDO1 inhibitorsGENENTECH INC·Filed 2018·Granted Mar 14, 2023·2 cites·17 claims
- 1473US6525036B2Compounds and compositions as protease inhibitorsMERCK & CO INC·Filed 2001·Granted Feb 25, 2003·8 cites·25 claims
- 1572US2022204517A1Inhaled powder formulationsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1671US2020002345A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2019·Application pending·0 cites
- 1769US2019322661A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1864US2017283424A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2017·Application pending·0 cites
- 1964US2018305355A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2061US2020165260A1Inhaled powder formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2160US2017145020A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2256US2018265515A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2354US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 2454US2015152117A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 2553US12473301B2Isoquinoline compounds for the treatment of cancerGENENTECH INC·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 2653US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 2753US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 2845US2003092634A1Novel compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rohan Mendonca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →